Form 424B3 InMed Pharmaceuticals
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20261001/AS22V22GZC2RVTZ2222B2ZYSDJA9EZ223282
Filed on: October 1, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- A Landmark Flight, Culinary Festivals and Endless Summer: October in The Bahamas
- Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair
- Curriculum Associates Welcomes New Class of School Leaders to Extraordinary Educators™ Leadership Collaborative
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
